Paula Lorgelly, University of Auckland, Waipapa Taumata Rau
Cancer patients will benefit from the investment but so will people with other health conditions because the funding also covers medicines that Pharmac ranked as more important.
Paula Lorgelly, University of Auckland, Waipapa Taumata Rau
The government says funding for COVID vaccines and antivirals are up for consideration next year. With so much unknown about the long-term impact of COVID, will cost become a barrier to access?
Paula Lorgelly, University of Auckland, Waipapa Taumata Rau
Most parties are promising more funding for the government drug-buying agency. But two likely coalition partners are suggesting a new – and possibly risky – approach to medicines procurement.